Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Telix IsoTherapeutics Group, Inc.
FDA Inspection
•Telix IsoTherapeutics Group, Inc.•July 31, 2025

Telix IsoTherapeutics Group, Inc. – FDA Inspection, Jul 31, 2025

Record Details

This FDA Inspection record concerns Telix IsoTherapeutics Group, Inc., with an inspection on July 31, 2025, issued by the Dallas District Office, covering animal drugs & feeds.

Company
Telix IsoTherapeutics Group, Inc.
Inspection Date
July 31, 2025
Product Type
Animal Drugs & Feeds
Office
Dallas District Office
People
  • Cameron E. Moore (Issuing Officer)
  • Camerson E. Moore (FDA Associated Person)
  • Mercedes N. Overton (Issuing Officer)
View Company Profile

ID · 00ed8c68-0d69-4e9f-a178-27095a6fa684

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1277105
FDA center
Animal Drugs & Feeds
Project area
Monitoring of Marketed Animal Drugs, Feeds, and Devices
Outcome
Form 483 issued, view the record

FDA Citations

10
  1. 21 CFR 211.113(b)Procedures for sterile drug products
  2. 21 CFR 211.160(a)Lab controls established, including changes
  3. 21 CFR 211.192Quality control unit review of records
  4. 21 CFR 211.198(a)Procedures to be written and followed
  5. 21 CFR 211.22(d)Procedures not in writing, fully followed
  6. 21 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
  7. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  8. 21 CFR 211.58Buildings not maintained in good state of repair
  9. 21 CFR 211.63Equipment Design, Size and Location
  10. 21 CFR 211.68(b)Backup data not assured as exact and complete

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Telix IsoTherapeutics Group, Inc.

3
DateClassificationOfficeProject area
February 3, 2020NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 17, 2019VAIDallas District OfficeGeneric Drug Evaluation
November 30, 2016NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Telix IsoTherapeutics Group, Inc.
  • FDA Inspection 1117578 - 2020-02-03
  • FDA Inspection 1089897 - 2019-05-17
  • FDA Inspection 994402 - 2016-11-30

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Telix IsoTherapeutics Group, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.